- Home
- MGNI vs INMD Comparison
MGNI vs INMD Comparison
Compare MGNI & INMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MGNI
- INMD
- Stock Information
- Founded
- MGNI 2007
- INMD 2008
- Country
- MGNI United States
- INMD Israel
- Employees
- MGNI N/A
- INMD N/A
- Industry
- MGNI Computer Software: Programming Data Processing
- INMD Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- MGNI Technology
- INMD Health Care
- Exchange
- MGNI Nasdaq
- INMD Nasdaq
- Market Cap
- MGNI 1.7B
- INMD 1.4B
- IPO Year
- MGNI N/A
- INMD 2019
- Fundamental
- Price
- MGNI $15.87
- INMD $18.01
- Analyst Decision
- MGNI Strong Buy
- INMD Buy
- Analyst Count
- MGNI 12
- INMD 6
- Target Price
- MGNI $17.05
- INMD $22.60
- AVG Volume (30 Days)
- MGNI 2.2M
- INMD 1.1M
- Earning Date
- MGNI 11-07-2024
- INMD 10-30-2024
- Dividend Yield
- MGNI N/A
- INMD N/A
- EPS Growth
- MGNI N/A
- INMD N/A
- EPS
- MGNI 0.12
- INMD 1.84
- Revenue
- MGNI $661,134,000.00
- INMD $423,746,000.00
- Revenue This Year
- MGNI $0.39
- INMD N/A
- Revenue Next Year
- MGNI $10.90
- INMD $3.13
- P/E Ratio
- MGNI $133.24
- INMD $9.80
- Revenue Growth
- MGNI 8.71
- INMD N/A
- 52 Week Low
- MGNI $7.61
- INMD $14.87
- 52 Week High
- MGNI $17.00
- INMD $26.80
- Technical
- Relative Strength Index (RSI)
- MGNI 77.56
- INMD 49.83
- Support Level
- MGNI $12.42
- INMD $19.11
- Resistance Level
- MGNI $17.00
- INMD $19.85
- Average True Range (ATR)
- MGNI 0.72
- INMD 0.62
- MACD
- MGNI 0.50
- INMD -0.01
- Stochastic Oscillator
- MGNI 90.24
- INMD 37.20
About MGNI Magnite Inc.
Magnite is one of the largest supply-side platform providers, or SSP, in online advertising. The firm was previously named The Rubicon Project (an online ad exchange) and became Magnite after merging with Telaria (an SSP focused mainly on streaming video providers) in 2020. The firm also purchased another of the leading SSPs within the CTV market, SpotX, in 2021 for $1.2 billion, cementing its long-term focus on grabbing market share in this area. The firm generates nearly 45% of its revenue from the programmatic sale of CTV ad inventory, 35% from mobile online sites and apps, and the remaining from websites accessed via computer.
About INMD InMode Ltd.
InMode Ltd provides minimally and non-invasive surgical aesthetic and medical treatment solutions in the United States. Its products and solutions address three energy-based treatment categories that include face & body contouring, medical aesthetics, and women's health. InMode has developed products using its technology for plastic surgery, dermatology, gynecology, and ophthalmology. Its product platforms include BodyTite, Optimas, Votiva, Contoura, Triton, EmbraceRF, EvolveX, Evoke, EmpowerRF and Morpheus8. The majority of its revenue comes from the United States.